Latest Breaking News On - Tumor cell - Page 9 : comparemela.com

 E-Mail IMAGE: Zhenyu Yue, PhD, Professor of Neurology and Neuroscience, Director of Basic and Translational Research of Movement Disorders, Icahn School of Medicine at Mount Sinai and senior author of the paper. view more  Credit: Mount Sinai Health System Mount Sinai Researchers Find Removal of AKAP11 Protein by Autophagy as a key to Fuel Mitochondrial Metabolism and Tumor Cell Growth through activating protein kinase A (PKA) (Patent pending) Corresponding Author: Zhenyu Yue, PhD, Professor of Neurology, Aidekman Family Professorship, Director of Basic and Translational Research in Movement Disorders, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai. Bottom Line: We uncovered a mechanism that tumor cells exploit selective autophagy for metabolic reprogramming that benefits tumor cell growth and offers resistance to glucose deprivation. Our study suggests that AKAP220-mediated autophagy as a novel therapeutic target for specific cancer treatment

Elizabeth dowlingZhenyu yueWhy the research is interestingTranslational research in movement disordersIcahn school of medicine at mount sinaiPublic affairsFriedman brain instituteMount sinai researchers findFuel mitochondrial metabolismTumor cell growthAidekman family professorshipTranslational researchMovement disordersIcahn schoolResearch is interestingSelective autophagy